Contracts › 75F40125F80062
75F40125F80062: Biosimilar and Interchangeable Continuing Education
Awarded to Webmd Health Corp. by Food and Drug Administration (FDA).
$2.2Mobligated
$6.5Mpotential value
29 August 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40125F80062 |
|---|---|
| Vehicle | GS02F0034W |
| Awardee | Webmd Health Corp. |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 611430 Professional and Management Development Training |
| PSC | R425 Support- Professional: Engineering/Technical |
| Place of performance | NJ |
| Offers received | 1 |
| Period of performance | 29 April 2025 to 29 August 2027 |
| Potential end | 29 August 2030 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 611430 contracts · All expiring contracts · USASpending record